Get started
Author

Alexis Marguerit

Observed name: A. Marguerit
ORCID: 0000-0002-2281-3999
Observed ORCID: 0000-0002-2281-3999
OpenAlex ID: A5011238982
Stereotactic MR-Guided Radiotherapy for Adrenal Gland Metastases: First Clinical Results
2022 · Morgan Michalet, Ons Bettaïeb, et al. · Journal of Clinical Medicine · 22
PDF
Radiotherapy in the management of synchronous metastatic lung cancer
2023 · J. Khalifa, A. Lévy, et al. · Cancer/Radiothérapie · 4
Radiotherapy for lung metastases
2025 · Antonin Levy, Marion Tonneau, et al. · Cancer/Radiothérapie · 3
Radiotherapy for primary lung cancer: 2025 update
2025 · Jonathan Khalifa, Yasmine El Houat, et al. · Cancer/Radiothérapie · 1
Outcome of Normofractionated Stereotactic Photon Boost Compared With Proton Boost for The Treatment of Spinal or Skull-Base Chordomas and Chondrosarcomas
2026 · Marie-Colombe Schmittbiel, Marie Vidal, et al. · International Journal of Particle Therapy
Factors Associated With Treatment Delays in Proton Therapy
2026 · Jerôme Doyen, Line Claude, et al. · International Journal of Particle Therapy
821 Two decades of insight: key findings from a French retrospective multicenter analysis of pediatric localized intracranial ependymoma (NCT05151718)
2026 · Fatima TENSAOUTI, Alexis Marguerit, et al. · Radiotherapy and Oncology
Unusual Case of Neuromeningeal Late Relapse of POLE Mutated Endometrioid Carcinoma: A Case Report and Systematic Review
2026 · Emma Donati, Michel Fabbro, et al. · Current Oncology
PDF
3282 Pediatric localized intracranial ependymoma: survival, prognostic factors in a French multicentric retrospective study from 2000 to 2021 (NCT05151718)
2025 · Alexis Marguerit, Fatima Tensaouti, et al. · Radiotherapy and Oncology
1249 Radiomics prognostication model in pediatric ependymoma using diffusion-weighted imaging (NCT05151718)
2025 · Fatima Tensaouti, Nhi Blanchard, et al. · Radiotherapy and Oncology
Radiotherapy in the management of lung oligometastases
2024 · V. Bourbonne, A. Lévy, et al. · Cancer/Radiothérapie
Radiothérapie stéréotaxique (RTST) pulmonaire des tumeurs de moins de 3 cm (stade I) et 5 cm (stade II) non opérées : 10 ans d’expérience de l’Institut du Cancer de Montpellier (ICM)
2023 · A. Marguerit, D. Azria, et al. · Cancer/Radiothérapie
Works count: 12
Citation count: 30
H-index: 3
I10-index: 1
Year
Topic
Type